Medicinal plants possessed anti-Parkinsonian effects with emphasis on their mechanisms of action

Authors

  • Ali Esmail Al-Snafi Dept. of Pharmacology, College of Medicine, University of Thi-Qar, Iraq.

DOI:

https://doi.org/10.30574/gscbps.2021.17.1.0320

Keywords:

Medicinal plants, Parkinsonʼs disease, Anti-Parkinsonian, Mechanisms

Abstract

Parkinsonʼs disease is a progressive neurodegenerative dysfunction characterized by the loss of dopaminergic neurons of the nigrostriatal system. Dopamine is important to maintain normal movement patterns. The cardinal physical signs of the disease are distal resting tremor, rigidity, bradykinesia, and asymmetric onset. Treatment aims to improve these motor symptoms. Many medicinal plants possessed Parkinsonian effects by different mechanisms, included inhibition of α-synuclein condensation, reduction of oxidative stress and neuro-inflammation, increase of dopaminergic neurons survival, blockade of the adenosine A2A receptor and regulation of molecular pathways involved in neuronal survival such as MAPK, Nrf2, and NF-κB, thus exerted neuroprotective actions. In the present review, we highlight the medicinal plants with potential anti-Parkinsonian effects with discussing the mechanisms of their beneficial effects.

Metrics

Metrics Loading ...

References

Ríos JL, Onteniente M, Picazo D, Montesinos MC. Medicinal Plants and Natural Products as Potential Sources for Antiparkinson Drugs. Planta Med. Jul 2016; 82(11-12): 942-51.

Church FC. Treatment options for motor and non-motor symptoms of Parkinson’s disease. Biomolecules 2021; 11: 612.

Al-Snafi AE. Therapeutic properties of medicinal plants: a review of medicinal plants with central nervous effects (part 1). Int J of Pharmacology & Toxicology. 2015; 5(3): 177-192.

Al-Snafi AE. Medicinal plants with central nervous effects (part 2): plant based review. IOSR Journal of Pharmacy. 2016; 6(8): 52-75.

Al-Snafi AE, Talab TA, Majid WJ. Medicinal plants with central nervous activity - An overview (Part 1). IOSR Journal of pharmacy. 2019; 9(3): 52-102.

Mazo NA, Echeverria V, Cabezas R, Avila-Rodriguez M, Tarasov VV, Yarla NS, Aliev G, Barreto GE. Medicinal Plants as Protective Strategies Against Parkinson's Disease. Curr Pharm Des. 2017; 23(28): 4180-4188.

Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020; 27(1): 27-42.

George VK, George A, Kopcke B, Roemer E,m Bitzer J, Gruenwald J, Gehling M, tengku A, tengku S, Torsten G. Aurones as selective pde inhibitors and their use in neurological conditions and disorders. Patent, Patrick Mirandah. 2009.

Al-Snafi AE. The pharmacological importance of Antirrhinum majus - A review. Asian J of Pharm Sci & Tech. 2015; 5(4): 313-320.

Jadiya P, Khan A, Sammi SR, Kaur S, Mir SS, Nazir A. Anti-Parkinsonian effects of Bacopamonnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson’s disease. Biochemical Biophysical Research Communications. 2012; 413(4): 605-610.

Al-Snafi AE.The pharmacology of Bacopamonniera. A review. International Journal of Pharma Sciences and Research. 2013; 4(12): 154-159.

Lin B. Polyphenols and neuroprotection against ischemia and neurodegeneration. Mini Rev Med Chem. 2011; 11(14): 1222-1238.

Al-Snafi AE. The chemical constituents and pharmacological importance of Carthamus tinctorius - An overview. Journal of Pharmaceutical Biology. 2015; 5(3): 143-166.

Zhu H, Wang Z, Ma C, Tian J, Fu F, Li C, Guo D, Roeder E, Liu K. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies. Planta Med. 2003; 69(5): 429-433.

Morshedi D, Aliakbari F, Tayaranian-Marvian A, Fassihi A, Pan-Montojo F, Pérez - Sánchez H. Cuminaldehyde as the major component ofCuminum cyminum, a natural aldehyde with inhibitory effect on alpha-synuclein fibrillation and cytotoxicity. J Food Sci. 2015; 80(10): H2336-2345.

Al-Snafi AE.The pharmacological activities of Cuminum cyminum - A review. IOSR Journal of Pharmacy. 2016; 6(6): 46-65.

Lee CH, Hwang DS, Kim HG, Oh H, Park H, Cho JH, Lee JM, Jang JB, Lee KS, Oh MS. Protective effect ofCyperirhizoma against 6-hydroxydopamine-induced neuronal damage. J Med Food. 2010; 13(3): 564-571.

Al-Snafi AE.A review on Cyperusrotundus A potential medicinal plant. IOSR Journal of Pharmacy. 2016; 6(7):32-48.

Lobbens ES, Breydo L, Skamris T, Vestergaard B, Jäger AK, Jorgensen L, Uversky V, van de Weert M. Mechanistic study of the inhibitory activity of Geumurbanum extract against α-Synuclein fibrillation. BiochimBiophysActa 2016; 1864(9): 1160-1169.

Al-Snafi AE. Constituents and pharmacology of Geumurbanum- A review. IOSR Journal of pharmacy 2019; 9(5): 28-33.

Sengupta T, Vinayagam J, Nagashayana N, et al.Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamusniger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency. Neurochem Res. 2011; 36: 177-186.

Al-Snafi AE.Therapeutic importance ofHyoscyamus species grown in Iraq (Hyoscyamusalbus, HyoscyamusnigerandHyoscyamus reticulates)- A review.IOSR Journal ofPharmacy. 2018; 8(6): 18-32.

Essa MM, Subash S, Dhanalakshmi C, Manivasagam T, Al-Adawi S, Guillemin GJ, Justin Thenmozhi A. Dietary supplementation of walnut partially reverses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced neurodegeneration in a mouse model of Parkinson's disease. Neurochem Res 2015; 40(6): 1283-1293.

Al-Snafi AE.Chemical constituents, nutritional, pharmacological and therapeutic importance of Juglans regia- A review. IOSR Journal of Pharmacy. 2018; 8(11): 1-21.

Bais S, Gill SdRana. Effect of Juniperus communis extract on reserpine induced catalepsy. Ethnopharmacology 2015; 4(4).

Al-Snafi AE.Medical importance of Juniperus communis - A review. Indo Am J P Sc. 2018; 5(3): 1979-1792.

Rana N, Bais S.Neuroprotective effect of J. communis in Parkinson disease induced animal models, MS thesis, Pharmacology Department, Punjab Technical University, Punjab, India. 2014.

Shastry CS, Kiran UP, Aswathanarayana BJ. Effect of acute and chronic administration of the aqueous extract of Lawsoniainermis leaves on haloperidol induced catalepsy in albino mice. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2012; 3(3): 1107- 1116.

Al-Snafi AE. A review on Lawsoniainermis:A potential medicinal plant. International Journal of Current Pharmaceutical Research. 2019; 11(5): 1-13.

Gandhare B. Protective effect of Luffa acutangula extract on haloperidol induced catalepsy in rats. International Journal of Experimental Pharmacology. 2012; 2(1): 37-43.

Al-Snafi AE. A review on Luffa acutangula: A potential medicinal plant. IOSR Journal of Pharmacy. 2019; 9(9): 56-67.

Wang X, Pang L, Zhang Y, Xu J, Ding D, Yang T, Zhao Q, Wu F, Li F, Meng H, Yu D. Lyciumbarbarum polysaccharide promotes nigrostriatal dopamine function by modulating PTEN/AKT/mTOR pathway in a methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP) murine model of Parkinson's disease. Neurochem Res. 2018; 43(4): 938-947.

Al-Snafi AE. Encyclopedia of chemical constituents and pharmacological effects of Iraqi medicinal plants. Rigi Publication. 2015.

Fahimi Z, Jahromy MH. Effects of blackberry (Morus nigra) fruit juice on levodopa- induced dyskinesia in a mice model of Parkinson's disease. J ExpPharmacol. 2018; 10: 29-35.

Sandhu K, Rana A. Evaluation of antiparkinson’s activity of Nigella sativa (Kalonji) seeds in chlorpromazine induced experimental animal model. Int J Pharm Pharm Sci. 2013; 5: 884-888.

Sedaghat R, Roghani M, Khalili M. Neuroprotective effect of thymoquinone, the Nigella sativa bioactive compound, in 6- hydroxydopamine-induced hemi-parkinsonian rat model. Iran J Pharm Res. 2014; 13: 227-234.

Aruna K, Rajeswari PDR, Sankar SR. The effect of Oxalis corniculata extract against the behavioral changes induced by 1- methyl- 4-phenyl-1,2,3,6-tetrahydro pyridine (MPTP) in mice. Journal of Applied Pharmaceutical Science. 2017; 7(03): 148-153.

Aruna K, Rajeswari PDR, Sankar SR. The effects of Oxalis corniculata L. extract against MPTP induced oxidative stress in mouse model of Parkinson’s disease. J Pharm Sci & Res. 2016; 8(10): 1136-1140.

Downloads

Published

2021-11-26

How to Cite

Al-Snafi, A. E. . (2021). Medicinal plants possessed anti-Parkinsonian effects with emphasis on their mechanisms of action. GSC Biological and Pharmaceutical Sciences, 17(1), 232–237. https://doi.org/10.30574/gscbps.2021.17.1.0320

Issue

Section

Review Article